# Breast cancer screening technology and efficacy

> Live situation record from CLSTR: https://clstr.news/situations/breast-cancer-screening-technology-and-efficacy
> Updated: 2026-10-26T04:10:07.000Z. Sources: 15. Developments: 2.

Medical discussions regarding breast cancer screening emphasize a personalized approach, utilizing various diagnostic tools such as digital mammography, ultrasound, and Magnetic Resonance Imaging (MRI) based on individual risk factors like age and breast density.

Recent research from a large German study, published in The Lancet Oncology and led by Stefanie Weigel from the University of Münster, suggests that 3D mammography, or tomosynthesis, may offer advantages over traditional 2D methods. The study, involving nearly 100,000 women aged 50 to 70 across 17 screening sites in North Rhine-Westphalia and Lower Saxony between 2018 and 2020, indicated a reduction in invasive interval cancer cases—tumors diagnosed shortly after a clear screening. While initial data showed a 24 to 29 percent relative reduction in these cases during the first year, researchers noted that the statistical difference between 3D and traditional mammography could not be clearly confirmed over a full two-year period.

Experts have further highlighted the limitations of mammography for women with dense breast tissue, a condition affecting nearly half of women aged 40 to 74. In such cases, mammography sensitivity can drop from 85–90% in fatty tissue to as low as 60–70% because dense tissue and tumors both appear white on X-rays, which can obscure abnormalities. To address these gaps, advanced imaging technologies are being utilized as complementary tools. MRI with contrast offers high diagnostic sensitivity and is particularly useful for women with extremely dense breasts or elevated genetic risks. While ultrasound may be recommended as an additional test, experts note that relying on ultrasound alone can miss up to 75% of breast cancers. Consequently, medical approaches are shifting toward individualized screening plans that consider age, density, family history, and overall risk profiles.

## Claims

- 3D mammography showed approximately 24 percent fewer interval breast cancer cases than traditional screening in a large German study. (corroborated by 4 sources)
- The statistical difference between the methods could not be clearly confirmed over a two-year period. (corroborated by 4 sources)
- 3D mammography (tomosynthesis) uses multiple X-ray images from different angles to create thin image layers. (corroborated by 4 sources)
- The study included 99,689 women aged 50 to 70 between 2018 and 2020. (single source)
- In the first year, the tomosynthesis group had 4.5 cases of invasive interval cancer per 10,000 women. (single source)
- The comparison group in the study had 6.3 cases of invasive interval cancer per 10,000 women. (single source)
- The relative reduction in interval cancer cases in the first year was 29 percent. (single source)
- The study was conducted across 17 screening locations in North Rhine-Westphalia and Lower Saxony. (single source)

## Timeline

### 2026-10-26: 3D Mammography shows potential for improved breast cancer detection

A German study published in The Lancet Oncology suggests 3D mammography may reduce interval breast cancer cases by 24 percent compared to traditional 2D screening.

9 sources. https://clstr.news/cluster/3d-mammography-shows-potential-in-reducing-interval-breast-cancer-cases

### 2026-10-24: Breast cancer screening: The role of MRI and ultrasound in dense tissue

Mammography is the standard for breast cancer screening, but dense breast tissue can obscure tumors. MRI and ultrasound serve as vital complementary tools for personalized, high-risk detection.

6 sources. https://clstr.news/cluster/breast-cancer-screening-choosing-between-mammography-ultrasound-and-mri

---
Cite as: Breast cancer screening technology and efficacy. CLSTR, https://clstr.news/situations/breast-cancer-screening-technology-and-efficacy